IGI Laboratories, Inc., Announces Changes To Its Senior Management Team
IGI Laboratories, Inc. (NYSE AMEX:IG), a premier provider of topical formulation development, analytical, manufacturing and packaging services today announced that effective February 12, 2010, Charles E. Moore has joined the Company in the newly created position of Executive Vice President of Technical Operations. Mr. Moore will report directly to Chief Executive Officer, Hem Pandya. In addition, the Company announced the promotion of Philip S. Forte to Chief Financial Officer. These key executive appointments will facilitate the next phase of the Company’s growth into becoming a leader in the topical and oral liquid pharmaceutical market.
Commenting on today's news, Mr. Pandya noted, "We are very pleased to welcome Charlie to IGI’s executive team. With over 25 years of pharmaceutical industry experience specifically in the field of dermatology, Charlie is a seasoned executive with a broad knowledge base in the areas of product development, commercial operations, logistics, business development, and sales. I would also like to congratulate Phil and look forward to working with him in his role as Chief Financial Officer. Phil as been a tremendous asset to the Company ever since joining IGI as Corporate Controller in May 2009. Together as a team we will successfully execute on the Company's business strategies."
Charles E. Moore is an experienced pharmaceutical executive with a successful track record in bringing over 50 generic topical products from development to approval. Prior to joining IGI, Mr. Moore was Vice President of Business Development for Infa Inc. where he was responsible for development of the North American business of the Infa Group, an Italian-based Active Pharmaceutical Ingredient (API) manufacturer. Mr. Moore has also served as Director of Business Development for VinChem Inc. From 1980 to 2006, Mr. Moore served in various senior management roles for Altana Inc. (now Nycomed) including being the Head of the Product Development Task Force. He was responsible for researching the US dermatology market, selecting the product candidates for in-house development, and overseeing the development process through ANDA approval and launch. Mr. Moore received his BSBA from Thomas A. Edison College.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV